Plain-English translation of NCT07045467 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This clinical trial is testing a new sedative medication called that may be used during kidney transplant surgery. Researchers want to understand how your body processes this medication and how effectively it keeps you sedated and comfortable during the procedure. The study will measure drug levels in your blood and monitor your sedation depth throughout surgery.
Currently, doctors use other sedative medications during transplant surgery, but this medication may offer more predictable and consistent sedation with fewer side effects. This study will help determine whether this treatment is safe and effective for use in kidney transplant patients.
You likely qualify if…
You likely don't qualify if…
You would receive the new sedative medication intravenously (through an IV) before and during your kidney transplant surgery. Doctors will take blood samples at different times to measure how your body processes the medication, and they will continuously monitor your sedation level and vital signs throughout the procedure. You will also have standard safety assessments including lab tests and physical exams before and after surgery.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
China